Privacy Policy
Signals Blog

Contributors

Categories

Cell therapies: how much will we pay?

Dr. Chih Wei Teng is Chief Operating Officer for CCRM Australia and wrote this blog with colleagues Alex Barrington and Dr. Emma Gallaher. To subscribe to the CCRM Australia newsletter: Click here  As stem cell therapies move through clinical trials and get closer to...

Bringing innovative cell and gene therapy products to Canadians

Siofradh McMahon is Senior Manager, Clinical Translation and Regulatory Affairs at CCRM. Síofradh works with academic and industry partners to advance promising products and technologies to commercialization. Having worked worldwide, Síofradh brings more than a decade...

Business of Regenerative Medicine Conference 2019: The rundown

Matthew Mistry is a Market and Equity Analyst at CCRM, where he conducts investment diligence, market analyses, participates in company creation activities and supports strategic business development. He joined CCRM from the Ontario Bioscience Innovation Organization...